ICU Medical

ICUI

Market cap $3.64B

SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in New York, December 2-4, 2025. ICU Medical's fireside chat will be on Thursday, December 4, 2025 at 10:00 a.m. PT (1:00 p.m. ET). Company management will also be participating in one-on-one meetings on Thursday, December 4, 2025.

ICU Medical (ICUI) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.59 per share a year ago.

ICU Medical, Inc. ( ICUI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Vivek Jain - CEO & Chairman of the Board Brian Bonnell - CFO & Treasurer Conference Call Participants Deirdre Thomson - ICR Inc. Jayson Bedford - Raymond James & Associates, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Matson - Needham & Company, LLC, Research Division Lawrence Solow - CJS Securities, Inc. Jason Bednar - Piper Sandler & Co., Research Division Presentation Operator Good afternoon, everyone, and welcome to ICU Medical's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that today's event is being recorded.

SAN CLEMENTE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2025.

SAN CLEMENTE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2025 earnings release and conference call.

ICU Medical, Inc. (NASDAQ:ICUI ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 8:30 AM EDT Company Participants Vivek Jain - CEO & Chairman of the Board Presentation Unknown Analyst Did you give me the disclosure? Did you say anything more?

ICUI faces an FDA recall of its Plum Duo Infusion System over software flaws, though devices remain in use, pending fixes.

SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September:

ICU Medical, Inc. (NASDAQ:ICUI ) Q2 2025 Earnings Call August 7, 2025 4:30 PM ET Company Participants Brian Michael Bonnell - CFO & Treasurer Vivek Jain - CEO & Chairman of the Board Conference Call Participants Charles S. Strauzer - CJS Securities, Inc. Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division Michael Toomey - Jefferies LLC, Research Division Michael Stephen Matson - Needham & Company, LLC, Research Division William Korner - Unidentified Company John Mills - ICR Inc. Operator Good afternoon, everyone, and welcome to today's ICU Medical Second Quarter 2025 Earnings Conference Call.

ICU Medical (ICUI 2.40%), a medical device company specializing in infusion therapy and related products, released its second quarter results on August 7, 2025. The most important news from the report was a significant earnings per share (EPS) beat, with adjusted EPS of $2.10 (Non-GAAP) compared to analyst expectations of $1.50, a positive difference of 40.0% (Non-GAAP).